Northern Trust’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.22M Sell
770,451
-8,307
-1% -$77.8K ﹤0.01% 2250
2025
Q1
$9.57M Sell
778,758
-13,992
-2% -$172K ﹤0.01% 2058
2024
Q4
$10.5M Buy
792,750
+55,144
+7% +$729K ﹤0.01% 2094
2024
Q3
$14.2M Buy
737,606
+40,877
+6% +$787K ﹤0.01% 1849
2024
Q2
$14.3M Sell
696,729
-45,098
-6% -$926K ﹤0.01% 1778
2024
Q1
$17.7M Buy
741,827
+63,722
+9% +$1.52M ﹤0.01% 1671
2023
Q4
$14.7M Buy
678,105
+42,580
+7% +$920K ﹤0.01% 1837
2023
Q3
$9.23M Sell
635,525
-28,942
-4% -$420K ﹤0.01% 2063
2023
Q2
$13.9M Buy
664,467
+69,543
+12% +$1.46M ﹤0.01% 1829
2023
Q1
$12.6M Buy
594,924
+45,833
+8% +$968K ﹤0.01% 1870
2022
Q4
$14M Buy
549,091
+45,129
+9% +$1.15M ﹤0.01% 1785
2022
Q3
$12.1M Buy
503,962
+16,049
+3% +$386K ﹤0.01% 1851
2022
Q2
$9.39M Buy
487,913
+1,685
+0.3% +$32.4K ﹤0.01% 2077
2022
Q1
$8.45M Buy
486,228
+32,552
+7% +$566K ﹤0.01% 2256
2021
Q4
$9.93M Sell
453,676
-4,500
-1% -$98.5K ﹤0.01% 2231
2021
Q3
$8.76M Sell
458,176
-761
-0.2% -$14.5K ﹤0.01% 2375
2021
Q2
$7.88M Buy
458,937
+93,451
+26% +$1.6M ﹤0.01% 2537
2021
Q1
$8.17M Buy
365,486
+17,712
+5% +$396K ﹤0.01% 2431
2020
Q4
$7.74M Buy
347,774
+6,864
+2% +$153K ﹤0.01% 2416
2020
Q3
$5.03M Sell
340,910
-13,839
-4% -$204K ﹤0.01% 2524
2020
Q2
$5.26M Buy
354,749
+79,134
+29% +$1.17M ﹤0.01% 2488
2020
Q1
$3.02M Buy
275,615
+34,066
+14% +$374K ﹤0.01% 2607
2019
Q4
$2.12M Sell
241,549
-2,164
-0.9% -$19K ﹤0.01% 3103
2019
Q3
$1.82M Buy
243,713
+55,631
+30% +$415K ﹤0.01% 3149
2019
Q2
$1.75M Buy
188,082
+11,470
+6% +$107K ﹤0.01% 3145
2019
Q1
$927K Buy
176,612
+1,120
+0.6% +$5.88K ﹤0.01% 3386
2018
Q4
$781K Buy
175,492
+2,690
+2% +$12K ﹤0.01% 3440
2018
Q3
$1.4M Sell
172,802
-2,075
-1% -$16.8K ﹤0.01% 3370
2018
Q2
$1.23M Buy
174,877
+31,146
+22% +$219K ﹤0.01% 3406
2018
Q1
$2.05M Sell
143,731
-10,270
-7% -$146K ﹤0.01% 3089
2017
Q4
$1.35M Buy
154,001
+26,724
+21% +$234K ﹤0.01% 3312
2017
Q3
$1.49M Sell
127,277
-2,919
-2% -$34.2K ﹤0.01% 3327
2017
Q2
$1.82M Buy
130,196
+63,336
+95% +$885K ﹤0.01% 3218
2017
Q1
$917K Buy
66,860
+6,758
+11% +$92.7K ﹤0.01% 3373
2016
Q4
$431K Buy
60,102
+7,151
+14% +$51.3K ﹤0.01% 3568
2016
Q3
$802K Buy
52,951
+2,736
+5% +$41.4K ﹤0.01% 3407
2016
Q2
$495K Buy
+50,215
New +$495K ﹤0.01% 3521